Bedel Financial Consulting, Inc.
Position in RLMD — Relmada Therapeutics, Inc.
CIK 1730511
INDIANAPOLIS, IN
Position in RLMD
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$69,600
+$21,300 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bedel Financial Consulting, Inc. holds $137,850 across 2 Biotechnology names. RLMD ranks #1 (50.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RLMD |
Relmada Therapeutics, Inc.
This page
|
10,000 | $69,600 | |
| 2 | IRD |
Opus Genetics, Inc.
|
15,000 | $68,250 |
All Filings in RLMD
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $69,600 | 10,000 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $48,300 | 10,000 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $20,100 | 10,000 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $6,000 | 10,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,700 | 10,000 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $5,200 | 10,000 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $32,400 | 10,000 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $30,000 | 10,000 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $46,500 | 10,000 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $41,400 | 10,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $30,000 | 10,000 | Shares | Sole | 2024-02-08 | |
| 2023-06-30 | $24,600 | 10,000 | Shares | Sole | 2023-08-10 | |
| No filing history on record for this holder in this stock. | ||||||